25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Aligned Genetics Inc
Buy, Hold or Sell?

Let's analyze Aligned Genetics Inc together

I guess you are interested in Aligned Genetics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aligned Genetics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aligned Genetics Inc

I send you an email if I find something interesting about Aligned Genetics Inc.

1. Quick Overview

1.1. Quick analysis of Aligned Genetics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Aligned Genetics Inc? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,177.60
Expected worth in 1 year
₩2,862.42
How sure are you?
77.8%

+ What do you gain per year?

Total Gains per Share
₩684.82
Return On Investment
21.2%

For what price can you sell your share?

Current Price per Share
₩3,230.00
Expected price per share
₩2,575 - ₩3,770
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Aligned Genetics Inc (5 min.)




Live pricePrice per Share (EOD)
₩3,230.00
Intrinsic Value Per Share
₩1,312.71 - ₩2,156.72
Total Value Per Share
₩3,490.31 - ₩4,334.32

2.2. Growth of Aligned Genetics Inc (5 min.)




Is Aligned Genetics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$21.9m$20.1m$1.7m7.9%

How much money is Aligned Genetics Inc making?

Current yearPrevious yearGrowGrow %
Making money$2.2m$1.6m$632.2k27.9%
Net Profit Margin21.3%17.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Aligned Genetics Inc (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Aligned Genetics Inc?

Welcome investor! Aligned Genetics Inc's management wants to use your money to grow the business. In return you get a share of Aligned Genetics Inc.

First you should know what it really means to hold a share of Aligned Genetics Inc. And how you can make/lose money.

Speculation

The Price per Share of Aligned Genetics Inc is ₩3,230. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aligned Genetics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aligned Genetics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,177.60. Based on the TTM, the Book Value Change Per Share is ₩171.21 per quarter. Based on the YOY, the Book Value Change Per Share is ₩129.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aligned Genetics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.160.0%0.160.0%0.110.0%0.110.0%0.040.0%
Usd Book Value Change Per Share0.120.0%0.120.0%0.090.0%0.100.0%0.170.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.120.0%0.120.0%0.090.0%0.100.0%0.170.0%
Usd Price Per Share2.82-2.82-5.27-6.10-6.70-
Price to Earnings Ratio17.91-17.91-46.41-411.91-186.81-
Price-to-Total Gains Ratio23.54-23.54-58.29-574.94-333.08-
Price to Book Ratio1.85-1.85-3.75-5.22-5.91-
Price-to-Total Gains Ratio23.54-23.54-58.29-574.94-333.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.261
Number of shares442
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.120.10
Usd Total Gains Per Share0.120.10
Gains per Quarter (442 shares)52.9744.86
Gains per Year (442 shares)211.88179.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102122020179169
204244140359348
306366260538527
408488380718706
50105910500897885
6012711262010771064
7014831474012561243
8016951686014351422
9019071898016151601
10021192110017941780

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.04.00.055.6%5.04.00.055.6%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.02.00.077.8%7.02.00.077.8%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.02.00.077.8%7.02.00.077.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Aligned Genetics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--171.206171.2060%129.187+33%144.982+18%241.955-29%
Book Value Per Share--2177.5992177.5990%2006.393+9%1802.412+21%1571.417+39%
Current Ratio--4.1244.1240%14.665-72%12.805-68%20.616-80%
Debt To Asset Ratio--0.2350.2350%0.218+8%0.195+20%0.146+61%
Debt To Equity Ratio--0.3070.3070%0.279+10%0.245+25%0.178+73%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--48326587990.00048326587990.0000%113917178690.000-58%129336500372.000-63%163605404938.750-70%
Eps--225.053225.0530%162.235+39%162.675+38%50.506+346%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--3.1763.1760%8.283-62%13.528-77%24.264-87%
Free Cash Flow Per Share--136.879136.8790%15.213+800%-34.460+125%-65.702+148%
Free Cash Flow To Equity Per Share--136.879136.8790%2.950+4540%7.613+1698%266.827-49%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2156.720--------
Intrinsic Value_10Y_min--1312.708--------
Intrinsic Value_1Y_max--19.606--------
Intrinsic Value_1Y_min---11.005--------
Intrinsic Value_3Y_max--208.674--------
Intrinsic Value_3Y_min--90.202--------
Intrinsic Value_5Y_max--578.301--------
Intrinsic Value_5Y_min--325.730--------
Market Cap46443847000.000-25%57946967000.00057946967000.0000%108273117000.000-46%125326492400.000-54%137685955777.778-58%
Net Profit Margin--0.2130.2130%0.170+25%0.185+15%-0.006+103%
Operating Margin----0%0.207-100%0.062-100%-0.0810%
Operating Ratio--1.0791.0790%1.155-7%1.269-15%1.441-25%
Pb Ratio1.483-25%1.8511.8510%3.753-51%5.219-65%5.906-69%
Pe Ratio14.352-25%17.90717.9070%46.414-61%411.911-96%186.812-90%
Price Per Share3230.000-25%4030.0004030.0000%7530.000-46%8716.000-54%9575.556-58%
Price To Free Cash Flow Ratio23.598-25%29.44229.4420%494.959-94%-16.182+155%-48.760+266%
Price To Total Gains Ratio18.866-25%23.53923.5390%58.288-60%574.941-96%333.083-93%
Quick Ratio--0.5090.5090%13.612-96%14.571-97%24.908-98%
Return On Assets--0.0790.0790%0.063+25%0.065+21%0.010+721%
Return On Equity--0.1030.1030%0.081+28%0.083+24%0.017+496%
Total Gains Per Share--171.206171.2060%129.187+33%144.982+18%241.955-29%
Usd Book Value--21918037.85521918037.8550%20194811.056+9%18141692.372+21%15816674.509+39%
Usd Book Value Change Per Share--0.1200.1200%0.090+33%0.101+18%0.169-29%
Usd Book Value Per Share--1.5241.5240%1.404+9%1.262+21%1.100+39%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--33828611.59333828611.5930%79742025.083-58%90535550.260-63%114523783.457-70%
Usd Eps--0.1580.1580%0.114+39%0.114+38%0.035+346%
Usd Free Cash Flow--1377714.2261377714.2260%153126.288+800%-346851.669+125%-661309.698+148%
Usd Free Cash Flow Per Share--0.0960.0960%0.011+800%-0.024+125%-0.046+148%
Usd Free Cash Flow To Equity Per Share--0.0960.0960%0.002+4540%0.005+1698%0.187-49%
Usd Market Cap32510692.900-25%40562876.90040562876.9000%75791181.900-46%87728544.680-54%96380169.044-58%
Usd Price Per Share2.261-25%2.8212.8210%5.271-46%6.101-54%6.703-58%
Usd Profit--2265212.4672265212.4670%1632929.823+39%1637357.827+38%508353.517+346%
Usd Revenue--10650289.01310650289.0130%9626805.524+11%7907210.156+35%5957662.667+79%
Usd Total Gains Per Share--0.1200.1200%0.090+33%0.101+18%0.169-29%
 EOD+4 -4MRQTTM+0 -0YOY+24 -125Y+23 -1310Y+17 -18

3.3 Fundamental Score

Let's check the fundamental score of Aligned Genetics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.352
Price to Book Ratio (EOD)Between0-11.483
Net Profit Margin (MRQ)Greater than00.213
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.509
Current Ratio (MRQ)Greater than14.124
Debt to Asset Ratio (MRQ)Less than10.235
Debt to Equity Ratio (MRQ)Less than10.307
Return on Equity (MRQ)Greater than0.150.103
Return on Assets (MRQ)Greater than0.050.079
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Aligned Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.150
Ma 20Greater thanMa 503,225.500
Ma 50Greater thanMa 1003,123.300
Ma 100Greater thanMa 2003,071.750
OpenGreater thanClose3,270.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Aligned Genetics Inc

Aligned Genetics, Inc., a biotech company, develops, manufactures, and sells imaging solutions for research institutions worldwide. The company offers solutions for digital cell imaging, and tissue clearing and 3D imaging. It offers its solutions through distributors. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-si, South Korea.

Fundamental data was last updated by Penke on 2025-01-21 16:24:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Aligned Genetics Inc earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Aligned Genetics Inc to the Medical Devices industry mean.
  • A Net Profit Margin of 21.3% means that ₩0.21 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aligned Genetics Inc:

  • The MRQ is 21.3%. The company is making a huge profit. +2
  • The TTM is 21.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ21.3%TTM21.3%0.0%
TTM21.3%YOY17.0%+4.3%
TTM21.3%5Y18.5%+2.7%
5Y18.5%10Y-0.6%+19.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ21.3%-6.4%+27.7%
TTM21.3%-13.8%+35.1%
YOY17.0%-14.5%+31.5%
5Y18.5%-14.5%+33.0%
10Y-0.6%-14.2%+13.6%
4.3.1.2. Return on Assets

Shows how efficient Aligned Genetics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aligned Genetics Inc to the Medical Devices industry mean.
  • 7.9% Return on Assets means that Aligned Genetics Inc generated ₩0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aligned Genetics Inc:

  • The MRQ is 7.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.9%TTM7.9%0.0%
TTM7.9%YOY6.3%+1.6%
TTM7.9%5Y6.5%+1.4%
5Y6.5%10Y1.0%+5.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9%-2.3%+10.2%
TTM7.9%-3.0%+10.9%
YOY6.3%-3.9%+10.2%
5Y6.5%-2.7%+9.2%
10Y1.0%-3.4%+4.4%
4.3.1.3. Return on Equity

Shows how efficient Aligned Genetics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aligned Genetics Inc to the Medical Devices industry mean.
  • 10.3% Return on Equity means Aligned Genetics Inc generated ₩0.10 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aligned Genetics Inc:

  • The MRQ is 10.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.3%TTM10.3%0.0%
TTM10.3%YOY8.1%+2.2%
TTM10.3%5Y8.3%+2.0%
5Y8.3%10Y1.7%+6.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ10.3%-2.8%+13.1%
TTM10.3%-3.9%+14.2%
YOY8.1%-4.0%+12.1%
5Y8.3%-4.0%+12.3%
10Y1.7%-4.9%+6.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Aligned Genetics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Aligned Genetics Inc is operating .

  • Measures how much profit Aligned Genetics Inc makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aligned Genetics Inc to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aligned Genetics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY20.7%-20.7%
TTM-5Y6.2%-6.2%
5Y6.2%10Y-8.1%+14.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.2%+13.2%
TTM--21.6%+21.6%
YOY20.7%-12.2%+32.9%
5Y6.2%-16.0%+22.2%
10Y-8.1%-15.1%+7.0%
4.3.2.2. Operating Ratio

Measures how efficient Aligned Genetics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are ₩1.08 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Aligned Genetics Inc:

  • The MRQ is 1.079. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.079. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.079TTM1.0790.000
TTM1.079YOY1.155-0.076
TTM1.0795Y1.269-0.190
5Y1.26910Y1.441-0.172
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0791.270-0.191
TTM1.0791.298-0.219
YOY1.1551.323-0.168
5Y1.2691.358-0.089
10Y1.4411.303+0.138
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Aligned Genetics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Aligned Genetics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 4.12 means the company has ₩4.12 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Aligned Genetics Inc:

  • The MRQ is 4.124. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.124. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.124TTM4.1240.000
TTM4.124YOY14.665-10.541
TTM4.1245Y12.805-8.681
5Y12.80510Y20.616-7.811
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1242.595+1.529
TTM4.1242.722+1.402
YOY14.6652.926+11.739
5Y12.8053.506+9.299
10Y20.6163.508+17.108
4.4.3.2. Quick Ratio

Measures if Aligned Genetics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aligned Genetics Inc to the Medical Devices industry mean.
  • A Quick Ratio of 0.51 means the company can pay off ₩0.51 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aligned Genetics Inc:

  • The MRQ is 0.509. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.509. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.509TTM0.5090.000
TTM0.509YOY13.612-13.103
TTM0.5095Y14.571-14.062
5Y14.57110Y24.908-10.337
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5091.465-0.956
TTM0.5091.586-1.077
YOY13.6121.889+11.723
5Y14.5712.360+12.211
10Y24.9082.548+22.360
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Aligned Genetics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Aligned Genetics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aligned Genetics Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.24 means that Aligned Genetics Inc assets are financed with 23.5% credit (debt) and the remaining percentage (100% - 23.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aligned Genetics Inc:

  • The MRQ is 0.235. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.235. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.2350.000
TTM0.235YOY0.218+0.017
TTM0.2355Y0.195+0.040
5Y0.19510Y0.146+0.049
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2350.401-0.166
TTM0.2350.404-0.169
YOY0.2180.368-0.150
5Y0.1950.428-0.233
10Y0.1460.449-0.303
4.5.4.2. Debt to Equity Ratio

Measures if Aligned Genetics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aligned Genetics Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 30.7% means that company has ₩0.31 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aligned Genetics Inc:

  • The MRQ is 0.307. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.307. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.307TTM0.3070.000
TTM0.307YOY0.279+0.028
TTM0.3075Y0.245+0.062
5Y0.24510Y0.178+0.067
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3070.572-0.265
TTM0.3070.619-0.312
YOY0.2790.547-0.268
5Y0.2450.643-0.398
10Y0.1780.715-0.537
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Aligned Genetics Inc generates.

  • Above 15 is considered overpriced but always compare Aligned Genetics Inc to the Medical Devices industry mean.
  • A PE ratio of 17.91 means the investor is paying ₩17.91 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aligned Genetics Inc:

  • The EOD is 14.352. Based on the earnings, the company is underpriced. +1
  • The MRQ is 17.907. Based on the earnings, the company is fair priced.
  • The TTM is 17.907. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD14.352MRQ17.907-3.555
MRQ17.907TTM17.9070.000
TTM17.907YOY46.414-28.507
TTM17.9075Y411.911-394.004
5Y411.91110Y186.812+225.099
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD14.352-1.483+15.835
MRQ17.907-1.747+19.654
TTM17.907-2.144+20.051
YOY46.414-2.985+49.399
5Y411.911-2.447+414.358
10Y186.812-2.141+188.953
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aligned Genetics Inc:

  • The EOD is 23.598. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 29.442. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 29.442. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD23.598MRQ29.442-5.845
MRQ29.442TTM29.4420.000
TTM29.442YOY494.959-465.517
TTM29.4425Y-16.182+45.624
5Y-16.18210Y-48.760+32.578
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD23.598-1.568+25.166
MRQ29.442-1.976+31.418
TTM29.442-2.193+31.635
YOY494.959-5.144+500.103
5Y-16.182-3.717-12.465
10Y-48.760-4.469-44.291
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Aligned Genetics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.85 means the investor is paying ₩1.85 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Aligned Genetics Inc:

  • The EOD is 1.483. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.851. Based on the equity, the company is underpriced. +1
  • The TTM is 1.851. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.483MRQ1.851-0.367
MRQ1.851TTM1.8510.000
TTM1.851YOY3.753-1.902
TTM1.8515Y5.219-3.368
5Y5.21910Y5.906-0.688
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.4832.148-0.665
MRQ1.8512.239-0.388
TTM1.8512.409-0.558
YOY3.7532.966+0.787
5Y5.2194.254+0.965
10Y5.9064.647+1.259
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Current Assets  37,39291,177128,568284,484413,052-128,070284,982-284,983-1
Other Current Liabilities  318,835266,621585,457322,270907,727-221,891685,836-685,8360
Retained Earnings  -8,903,400454,224-8,449,1765,512,813-2,936,3631,734,519-1,201,8442,881,8161,679,972



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets40,931,862
Total Liabilities9,620,379
Total Stockholder Equity31,311,483
 As reported
Total Liabilities 9,620,379
Total Stockholder Equity+ 31,311,483
Total Assets = 40,931,862

Assets

Total Assets40,931,862
Total Current Assets21,602,868
Long-term Assets19,328,994
Total Current Assets
Cash And Cash Equivalents 14,926,891
Net Receivables 2,667,100
Inventory 3,852,123
Total Current Assets  (as reported)21,602,868
Total Current Assets  (calculated)21,446,115
+/- 156,753
Long-term Assets
Property Plant Equipment 8,035,153
Intangible Assets 31,033
Long-term Assets Other 0
Long-term Assets  (as reported)19,328,994
Long-term Assets  (calculated)8,066,186
+/- 11,262,808

Liabilities & Shareholders' Equity

Total Current Liabilities5,238,030
Long-term Liabilities4,382,349
Total Stockholder Equity31,311,483
Total Current Liabilities
Short Long Term Debt 3,900,000
Accounts payable 164,901
Other Current Liabilities 0
Total Current Liabilities  (as reported)5,238,030
Total Current Liabilities  (calculated)4,064,901
+/- 1,173,130
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt763,075
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)4,382,349
Long-term Liabilities  (calculated)763,076
+/- 3,619,273
Total Stockholder Equity
Retained Earnings 1,679,972
Total Stockholder Equity (as reported)31,311,483
Total Stockholder Equity (calculated)1,679,972
+/- 29,631,511
Other
Capital Stock7,189,448
Common Stock Shares Outstanding 14,379
Net Invested Capital 35,211,483
Net Working Capital 16,364,837
Property Plant and Equipment Gross 9,147,665



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
6,858,834
25,860,714
24,307,065
23,000,867
24,619,170
25,481,065
34,469,498
36,901,487
40,931,862
40,931,86236,901,48734,469,49825,481,06524,619,17023,000,86724,307,06525,860,7146,858,834
   > Total Current Assets 
5,797,886
24,350,763
22,289,264
17,433,706
17,294,374
15,941,740
18,385,607
19,551,899
21,602,868
21,602,86819,551,89918,385,60715,941,74017,294,37417,433,70622,289,26424,350,7635,797,886
       Cash And Cash Equivalents 
3,239,918
9,308,889
7,405,383
2,866,120
4,897,966
5,638,753
5,278,398
9,442,204
14,926,891
14,926,8919,442,2045,278,3985,638,7534,897,9662,866,1207,405,3839,308,8893,239,918
       Short-term Investments 
290,437
12,255,348
12,103,000
4,050,505
9,001,000
6,500,000
7,000,000
3,000,000
0
03,000,0007,000,0006,500,0009,001,0004,050,50512,103,00012,255,348290,437
       Net Receivables 
515,517
966,382
1,237,110
1,215,242
1,158,873
1,274,304
2,130,155
1,451,275
2,667,100
2,667,1001,451,2752,130,1551,274,3041,158,8731,215,2421,237,110966,382515,517
       Inventory 
1,510,766
1,710,914
1,358,546
2,152,993
2,119,986
2,109,784
2,353,322
3,759,163
3,852,123
3,852,1233,759,1632,353,3222,109,7842,119,9862,152,9931,358,5461,710,9141,510,766
       Other Current Assets 
290,437
90,339
68,765
123,601
37,392
128,568
413,052
284,982
-1
-1284,982413,052128,56837,392123,60168,76590,339290,437
   > Long-term Assets 
0
0
0
0
0
9,539,325
16,083,891
17,349,588
19,328,994
19,328,99417,349,58816,083,8919,539,32500000
       Property Plant Equipment 
455,259
450,850
669,984
675,787
2,038,944
1,672,757
5,775,730
7,285,195
8,035,153
8,035,1537,285,1955,775,7301,672,7572,038,944675,787669,984450,850455,259
       Long Term Investments 
0
0
0
3,720,841
4,320,556
0
0
0
0
00004,320,5563,720,841000
       Intangible Assets 
604,049
1,021,317
740,314
562,944
374,682
223,939
101,081
64,347
31,033
31,03364,347101,081223,939374,682562,944740,3141,021,317604,049
       Long-term Assets Other 
0
0
0
0
0
0
0
1
0
010000000
> Total Liabilities 
796,040
1,678,079
1,666,845
2,112,790
3,652,665
4,017,430
7,477,334
8,051,757
9,620,379
9,620,3798,051,7577,477,3344,017,4303,652,6652,112,7901,666,8451,678,079796,040
   > Total Current Liabilities 
265,180
651,054
596,202
701,090
901,233
1,219,430
1,417,316
1,333,199
5,238,030
5,238,0301,333,1991,417,3161,219,430901,233701,090596,202651,054265,180
       Short Long Term Debt 
0
0
0
0
0
0
0
0
3,900,000
3,900,00000000000
       Accounts payable 
2,580
82,990
41,781
72,475
157,399
278,438
144,458
134,258
164,901
164,901134,258144,458278,438157,39972,47541,78182,9902,580
       Other Current Liabilities 
142,104
339,152
434,691
478,164
318,835
585,457
907,727
685,836
0
0685,836907,727585,457318,835478,164434,691339,152142,104
   > Long-term Liabilities 
0
0
0
0
0
2,798,000
6,060,018
6,718,558
4,382,349
4,382,3496,718,5586,060,0182,798,00000000
       Long term Debt Total 
0
0
0
0
994,024
916,766
4,220,969
4,143,965
0
04,143,9654,220,969916,766994,0240000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
1,128,356
535,734
479,281
763,075
763,075479,281535,7341,128,35600000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
1
100000000
       Deferred Long Term Liability 
528,850
876,983
472,765
293,324
166,196
71,516
1
0
0
00171,516166,196293,324472,765876,983528,850
> Total Stockholder Equity
6,062,794
24,182,635
22,640,220
20,888,077
20,966,505
21,463,635
26,992,164
28,849,730
31,311,483
31,311,48328,849,73026,992,16421,463,63520,966,50520,888,07722,640,22024,182,6356,062,794
   Common Stock
1,350,113
1,780,862
1,797,362
1,797,362
1,797,362
3,594,724
3,594,724
3,594,724
0
03,594,7243,594,7243,594,7241,797,3621,797,3621,797,3621,780,8621,350,113
   Retained Earnings 
-3,585,720
-5,486,137
-7,203,390
-8,978,193
-8,903,400
-8,449,176
-2,936,363
-1,201,844
1,679,972
1,679,972-1,201,844-2,936,363-8,449,176-8,903,400-8,978,193-7,203,390-5,486,137-3,585,720
   Capital Surplus 
8,315,575
27,901,502
28,056,314
28,056,314
28,056,314
26,258,952
26,258,952
26,258,952
0
026,258,95226,258,95226,258,95228,056,31428,056,31428,056,31427,901,5028,315,575
   Treasury Stock000000000
   Other Stockholders Equity 
-17,173
-13,592
-10,066
12,594
16,229
59,136
74,851
197,899
0
0197,89974,85159,13616,22912,594-10,066-13,592-17,173



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue15,214,699
Cost of Revenue-4,544,865
Gross Profit10,669,83410,669,834
 
Operating Income (+$)
Gross Profit10,669,834
Operating Expense-11,877,618
Operating Income3,337,081-1,207,784
 
Operating Expense (+$)
Research Development1,684,327
Selling General Administrative1,574,127
Selling And Marketing Expenses0
Operating Expense11,877,6183,258,454
 
Net Interest Income (+$)
Interest Income161,064
Interest Expense-214,881
Other Finance Cost-0
Net Interest Income-53,817
 
Pretax Income (+$)
Operating Income3,337,081
Net Interest Income-53,817
Other Non-Operating Income Expenses0
Income Before Tax (EBT)3,424,1773,337,081
EBIT - interestExpense = -214,881
3,236,018
3,450,899
Interest Expense214,881
Earnings Before Interest and Taxes (EBIT)03,639,058
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax3,424,177
Tax Provision-188,159
Net Income From Continuing Ops3,236,0183,236,018
Net Income3,236,018
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net053,817
 

Technical Analysis of Aligned Genetics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aligned Genetics Inc. The general trend of Aligned Genetics Inc is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aligned Genetics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aligned Genetics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3,370 < 3,640 < 3,770.

The bearish price targets are: 2,975 > 2,950 > 2,575.

Tweet this
Aligned Genetics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aligned Genetics Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aligned Genetics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aligned Genetics Inc. The current macd is 39.14.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aligned Genetics Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Aligned Genetics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Aligned Genetics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Aligned Genetics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAligned Genetics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aligned Genetics Inc. The current adx is 25.20.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aligned Genetics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Aligned Genetics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aligned Genetics Inc. The current sar is 3,118.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Aligned Genetics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aligned Genetics Inc. The current rsi is 53.15. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Aligned Genetics Inc Daily Relative Strength Index (RSI) ChartAligned Genetics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aligned Genetics Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aligned Genetics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Aligned Genetics Inc Daily Stochastic Oscillator ChartAligned Genetics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aligned Genetics Inc. The current cci is -5.3046595.

Aligned Genetics Inc Daily Commodity Channel Index (CCI) ChartAligned Genetics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aligned Genetics Inc. The current cmo is 2.73899715.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Aligned Genetics Inc Daily Chande Momentum Oscillator (CMO) ChartAligned Genetics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aligned Genetics Inc. The current willr is -56.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Aligned Genetics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Aligned Genetics Inc Daily Williams %R ChartAligned Genetics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aligned Genetics Inc.

Aligned Genetics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aligned Genetics Inc. The current atr is 110.90.

Aligned Genetics Inc Daily Average True Range (ATR) ChartAligned Genetics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aligned Genetics Inc. The current obv is 24,562,674.

Aligned Genetics Inc Daily On-Balance Volume (OBV) ChartAligned Genetics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aligned Genetics Inc. The current mfi is 52.21.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Aligned Genetics Inc Daily Money Flow Index (MFI) ChartAligned Genetics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aligned Genetics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Aligned Genetics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aligned Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.150
Ma 20Greater thanMa 503,225.500
Ma 50Greater thanMa 1003,123.300
Ma 100Greater thanMa 2003,071.750
OpenGreater thanClose3,270.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Aligned Genetics Inc with someone you think should read this too:
  • Are you bullish or bearish on Aligned Genetics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aligned Genetics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aligned Genetics Inc

I send you an email if I find something interesting about Aligned Genetics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Aligned Genetics Inc.

Receive notifications about Aligned Genetics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.